Health Care

French authorities are searching five sites run by dairy giant Lactalis in an investigation into the botched mass recall of baby milk products after a salmonella scare.

U.S. regulators have approved the first drug aimed at women with advanced breast cancers caused by an inherited flawed gene.

The federal government on Friday granted the first U.S. state, Kentucky, approval to implement work requirements for Medicaid beneficiaries.

French President Emmanuel Macron's government is scrambling to save face after the alarming failure of a mass recall of baby milk prompted by a salmonella scare.

Kairos founder Ankur Jain discusses why one of the biggest trends for 2018 will be baby boomers becoming the new millennials.

U.S. health officials plan to crack down on a growing number of unproven alternative remedies, focusing on those containing dangerous ingredients that have occasionally been linked to serious injury and death.

A Pennsylvania judge overturned a $28 million jury award to a couple who accused Bayer and J&J of failing to warn about risks connected to their drug Xarelto.

If Amazon enters the pharmaceutical business it has the capacity to revolutionize the entire system as we know it, experts suggest.

Toyota is recalling 601,000 more vehicles in the U.S. to replace defective and potentially deadly Takata air bag inflators.

President Donald Trump's pick for health secretary is telling senators he's wary of a broad government role in negotiating prescription drug prices.

Alzheimer’s is going to cripple the U.S., if a disease modifying agent isn’t soon discovered, Merck’s (NYSE:MRK) CEO Ken Frazier told FOX Business’ Maria Bartiromo on ‘Mornings with Maria.”

Mylan CEO Heather Bresch tells FOX Business the company took care of the EpiPen problem and is focusing on new drugs in its pipeline.

Danish drugmaker Novo Nordisk has revised up its offer for Belgian biotech company Ablynx as it looks to find growth opportunities beyond its core business.

An $11 billion burst of biotech bids in just four days has fueled expectations of a 2018 surge in life science deals as large drugmakers shop for promising assets from smaller rivals.

American families are putting off health care treatments until their tax refund is delivered to their bank accounts, according to a new study.